ArticleJCO oncology advances2024

Clinical Outcomes and Efficacy of Human Epidermal Growth Factor Receptor 2-Targeted Therapy in Breast Cancer With Uncommon In Situ Hybridization Patterns or Discordant Immunohistochemistry.

Qianchen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.